Patent · US Active

Anxiolytic compounds

US8293737B2 · kind B2 · utility

10Cited by
42References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2007
Grant dateOct 23, 2012
Priority date
Expiry dateDec 1, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to chemical compounds of general formula (I)which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.